116 related articles for article (PubMed ID: 25662585)
1. Dose-limiting inhibition of acetylcholinesterase by ladostigil results from the rapid formation and fast hydrolysis of the drug-enzyme complex formed by its major metabolite, R-MCPAI.
Moradov D; Finkin-Groner E; Bejar C; Sunita P; Schorer-Apelbaum D; Barasch D; Nemirovski A; Cohen M; Weinstock M
Biochem Pharmacol; 2015 Mar; 94(2):164-72. PubMed ID: 25662585
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory effects of ladostigil and its metabolites in aged rat brain and in microglial cells.
Panarsky R; Luques L; Weinstock M
J Neuroimmune Pharmacol; 2012 Jun; 7(2):488-98. PubMed ID: 22454040
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of memantine has no effect on the in vitro or ex vivo determined acetylcholinesterase inhibition of rivastigmine in the rat brain.
Enz A; Gentsch C
Neuropharmacology; 2004 Sep; 47(3):408-13. PubMed ID: 15275830
[TBL] [Abstract][Full Text] [Related]
4. Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.
Geerts H; Guillaumat PO; Grantham C; Bode W; Anciaux K; Sachak S
Brain Res; 2005 Feb; 1033(2):186-93. PubMed ID: 15694923
[TBL] [Abstract][Full Text] [Related]
5. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
[TBL] [Abstract][Full Text] [Related]
6. A fluorescence assay for measuring acetylcholinesterase activity in rat blood and a human neuroblastoma cell line (SH-SY5Y).
Santillo MF; Liu Y
J Pharmacol Toxicol Methods; 2015; 76():15-22. PubMed ID: 26165232
[TBL] [Abstract][Full Text] [Related]
7. The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Sagi Y; Driguès N; Youdim MB
Br J Pharmacol; 2005 Oct; 146(4):553-60. PubMed ID: 16086033
[TBL] [Abstract][Full Text] [Related]
8. Ladostigil: a novel multimodal neuroprotective drug with cholinesterase and brain-selective monoamine oxidase inhibitory activities for Alzheimer's disease treatment.
Weinreb O; Amit T; Bar-Am O; Youdim MB
Curr Drug Targets; 2012 Apr; 13(4):483-94. PubMed ID: 22280345
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent effects of ladostigil on microglial activation and cognition in aged rats.
Weinstock M; Bejar C; Schorer-Apelbaum D; Panarsky R; Luques L; Shoham S
J Neuroimmune Pharmacol; 2013 Mar; 8(1):345-55. PubMed ID: 23325108
[TBL] [Abstract][Full Text] [Related]
10. Effect of anti-dementia drugs on LPS induced neuroinflammation in mice.
Tyagi E; Agrawal R; Nath C; Shukla R
Life Sci; 2007 May; 80(21):1977-83. PubMed ID: 17395211
[TBL] [Abstract][Full Text] [Related]
11. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
[TBL] [Abstract][Full Text] [Related]
12. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
13. Prolonged treatment with donepezil increases acetylcholinesterase expression in the central nervous system.
Zivin M; Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):168-73. PubMed ID: 18587286
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of anti-inflammatory activity of hydroethanolic extract of Dilodendron bipinnatum Radlk.
de Oliveira RG; Mahon CP; Ascêncio PG; Ascêncio SD; Balogun SO; de Oliveira Martins DT
J Ethnopharmacol; 2014 Aug; 155(1):387-95. PubMed ID: 24930355
[TBL] [Abstract][Full Text] [Related]
15. The readthrough variant of acetylcholinesterase remains very minor after heat shock, organophosphate inhibition and stress, in cell culture and in vivo.
Perrier NA; Salani M; Falasca C; Bon S; Augusti-Tocco G; Massoulié J
J Neurochem; 2005 Aug; 94(3):629-38. PubMed ID: 16001972
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects of huperzine A, donepezil and rivastigmine on cortical acetylcholine level and acetylcholinesterase activity in rats.
Liang YQ; Tang XC
Neurosci Lett; 2004 May; 361(1-3):56-9. PubMed ID: 15135892
[TBL] [Abstract][Full Text] [Related]
17. Modification of acetylcholinesterase during adaptation to chronic, subacute paraoxon application in rat.
Milatovic D; Dettbarn WD
Toxicol Appl Pharmacol; 1996 Jan; 136(1):20-8. PubMed ID: 8560475
[TBL] [Abstract][Full Text] [Related]
18. Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).
Nochi S; Asakawa N; Sato T
Biol Pharm Bull; 1995 Aug; 18(8):1145-7. PubMed ID: 8535413
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation.
Tyagi E; Agrawal R; Nath C; Shukla R
Neurochem Int; 2010 Jan; 56(1):135-42. PubMed ID: 19781587
[TBL] [Abstract][Full Text] [Related]
20. PET imaging of brain acetylcholinesterase using [11C]CP-126,998, a brain selective enzyme inhibitor.
Bencherif B; Endres CJ; Musachio JL; Villalobos A; Hilton J; Scheffel U; Dannals RF; Williams S; Frost JJ
Synapse; 2002 Jul; 45(1):1-9. PubMed ID: 12112408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
